Design, synthesis and cytotoxic activity of molecular hybrids based on quinolin-8-yloxy and cinnamide hybrids and their apoptosis inducing property
The present work aims at design and synthesis of a congeneric series of small hybrids 5 and 6a-i featuring the privileged quinoline scaffold tethered with 2-(arylamido)cinnamide moiety as potential anticancer tubulin polymerization inhibitors. Most of the synthesized hybrids 5 and 6a-i significantly...
Saved in:
Published in | RSC advances Vol. 14; no. 16; pp. 11443 - 11451 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
03.04.2024
The Royal Society of Chemistry |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present work aims at design and synthesis of a congeneric series of small hybrids
5
and
6a-i
featuring the privileged quinoline scaffold tethered with 2-(arylamido)cinnamide moiety as potential anticancer tubulin polymerization inhibitors. Most of the synthesized hybrids
5
and
6a-i
significantly inhibited the growth of the HepG2 cell line, with IC
50
ranged from 2.46 to 41.31 μM. In particular, 2-(3,4,5-trimethoxybenzamido)-4-methoxycinnamide-quinoline hybrid
6e
displayed potent IC
50
value toward the examined cell line, and hence chosen for further mechanistic investigations. It is noteworthy that the antiproliferative action of compound
6e
highly correlated well with its ability to inhibit tubulin polymerization. In addition, the most potent hybrid
6e
demonstrated a significant modification in the cellular cycle distribution, in addition to provoke of apoptotic death within the tested HepG2 cell line. Furthermore, the mechanistic approach was confirmed by a substantial upregulation in the quantity of active
c
aspase 9 by 5.81-fold relative to untreated control cells.
A sequence of novel quinoline-8-yloxy and cinnamide hybrids has been synthesized and evaluated for
in vitro
cytotoxicity against HepG2 liver cancer cells. |
---|---|
Bibliography: | Electronic supplementary information (ESI) available. See DOI https://doi.org/10.1039/d4ra01911c ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/d4ra01911c |